Paclitaxel
- Product NDC
- 61703-015
- 11-digit product format
- 617030015
- Labeler code
- 61703
- Product ID
- 61703-015_f4f04a49-a3f6-40cd-b261-aa889a0b7d0d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PACLITAXEL
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Hospira, Inc.
- Application
- ANDA076131
- Marketing category
- ANDA
- Marketing start
- 2025-04-08
- Substance
- PACLITAXEL
- Active strength
- 6 mg/mL
- Pharmacologic classes
- Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| P88XT4IS4D | PACLITAXEL | 33069-62-4 | PACLITAXEL |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 61703-015-04 | 61703001504 | 1 VIAL, MULTI-DOSE in 1 CARTON (61703-015-04) / 5 mL in 1 VIAL, MULTI-DOSE | 2025-04-08 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Paclitaxel | Hospira, Inc. | Hospira Australia Pty Ltd | 2025-04-08 | HUMAN PRESCRIPTION DRUG LABEL | 32 |